LEP and breast cancer: The overexpression of leptin detected in triple-negative mammary carcinomas is also in concordance with previous results in triple-negative breast cancer, where leptin signaling is crucial for tumor growth (29, 63), being associated with ERK and Akt pathways, both involved in breast cancer cells proliferation (23).